The Patchless Patch Delivery System
MNP nanotechnology is broad based and amenable to formulating more than 60% of currently approved APIs.
We have achieved therapeutic blood levels with over 20 molecules from multiple therapeutic categories.
Key salient features of the MNP Nanoformulations:
SGN Nanopharma offers a much broader physicochemical property range of APIs that can be delivered via MNP as compared to other technologies.
Find out more about our key areas of application. Go to Research.